ATYR Latest Press Releases

-- September 1, 2026 --

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis Globe Newswire 4:36 PM

-- August 7, 2026 --

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD Globe Newswire 4:01 PM

-- July 15, 2026 --

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026 Globe Newswire 8:00 AM

-- June 26, 2026 --

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing Globe Newswire 8:35 AM

-- June 23, 2026 --

Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th Globe Newswire 8:35 AM

-- May 15, 2026 --

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update Globe Newswire 8:00 AM

-- May 13, 2026 --

aTyr Pharma to Participate in Upcoming Investor Conferences Globe Newswire 4:01 PM

-- May 11, 2026 --

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software